PBM:NSD-Psyence Biomedical Ltd. Common Shares (USD)

| Others |

Last Closing

USD 0.8589

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.08M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
QQQM Invesco NASDAQ 100 ETF

+1.16 (+0.64%)

USD 23.82B
ACWI iShares MSCI ACWI ETF

+0.61 (+0.55%)

USD 17.94B
IBIT iShares Bitcoin Trust

-0.93 (-2.58%)

USD 17.74B
CGABL The Carlyle Group Inc. 4.625% ..

-0.10 (-0.55%)

USD 16.14B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.16 (+0.30%)

USD 13.03B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.01 (+0.02%)

USD 3.07B
IBTE iShares iBonds Dec 2024 Term T..

-0.01 (-0.04%)

USD 2.82B
IBTF iShares iBonds Dec 2025 Term T..

N/A

USD 2.27B
NVDL GraniteShares 1.5x Long NVDA D..

+0.83 (+2.10%)

USD 2.05B
USCL iShares Climate Conscious & Tr..

+0.30 (+0.48%)

USD 2.01B

ETFs Containing PBM

TPMN Timothy Plan Market Neutr.. 23.73 % 0.00 %

+0.03 (+0%)

USD 0.04B
INDA 2.38 % 0.00 %

N/A

N/A
FEM First Trust Emerging Mark.. 0.00 % 0.80 %

+0.18 (+0%)

USD 0.44B
FEMS First Trust Emerging Mark.. 0.00 % 0.80 %

-0.05 (0%)

USD 0.32B
FGM First Trust Germany Alpha.. 0.00 % 0.80 %

+0.32 (+0%)

USD 9.82M
INDY iShares India 50 ETF 0.00 % 0.94 %

+0.28 (+0%)

USD 0.87B
UEVM VictoryShares Emerging Ma.. 0.00 % 0.45 %

+0.11 (+0%)

USD 0.18B
FLIN Franklin FTSE India ETF 0.00 % 0.19 %

+0.39 (+0%)

USD 1.03B
FTGG:XETRA First Trust Germany Alpha.. 0.00 % 0.00 %

-0.02 (0%)

USD 6.77M

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike